Key Events This Week
1 June: Intraday high of Rs.639.6 with a 7.39% gain
2 June: New 52-week and all-time high at Rs.663
3 June: New 52-week and all-time high at Rs.670.40, followed by a slight pullback
4 June: Modest gains with low volume
5 June: Closed week at Rs.676.10, up 2.24% on the day
Nephrocare Health Services Ltd Gains 10.92%: 7 Key Factors Driving the Surge
2026-06-13 09:00:58
Key Events This Week
8 Jun: New 52-week high at Rs.690.65 and all-time high at Rs.686.00
9 Jun: Multiple new highs including Rs.694.9 and intraday peak Rs.715.7 with 8.36% surge
10 Jun: New 52-week and all-time highs at Rs.725.15 and Rs.725.85
11 Jun: New 52-week high at Rs.760.85 and all-time high at Rs.760.50
12 Jun: New 52-week and all-time high at Rs.767.95, slight close dip of 0.19%

Nephrocare Health Services Ltd Hits All-Time High of Rs 767.95 as Momentum Builds Across Timeframes
2026-06-12 09:39:26After opening with a 2.01% gap up, Nephrocare Health Services Ltd touched a fresh all-time high of Rs 767.95 on 12 Jun 2026, marking a significant milestone in its recent rally despite a slight intraday pullback.
Read full news article
Broad-Based Technical Strength Lifts Nephrocare Health Services Ltd to 52-Week High of Rs 760.85
2026-06-11 15:37:41With a decisive surge to Rs 760.85 on 11 Jun 2026, Nephrocare Health Services Ltd has reached a fresh 52-week and all-time high, marking a significant milestone in its price momentum. This rally unfolds amid a broader market environment where the Sensex is retreating, underscoring the stock's relative strength and technical resilience.
Read full news article
Broad-Based Technical Strength Lifts Nephrocare Health Services Ltd to 52-Week High of Rs 725.15
2026-06-10 09:49:01With a decisive surge to Rs 725.15 on 10 Jun 2026, Nephrocare Health Services Ltd has reached a fresh 52-week and all-time high, propelled by a confluence of bullish technical indicators and sustained price momentum.
Read full news articleAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
11-Jun-2026 | Source : BSEPursuant to Regulation 30 of the SEBI Listing Regulations we hereby inform you that the Company has scheduled an Investor Conference Call as per the disclosure enclosed herewith.
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
10-Jun-2026 | Source : BSEPursuant to Reg 30 of SEBI LODR Regulations 2015 we hereby inform that Nephrocare Health Services Philippines Inc. overseas step-down wholly owned subsidiary of the company has acquired a Dialysis centre and has executed Asset Transfer Agreement as per the disclosure annexed herewith.
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
04-Jun-2026 | Source : BSEPursuant to Reg 30 of SEBI LODR Regulations 2015 we hereby inform that Nephrocare Health Services Philippines Inc. overseas step-down wholly owned subsidiary of the company has acquired a Dialysis centre and has executed Asset Transfer Agreement as per the disclosure annexed herewith.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available










